COCM
NVAX icon

Charter Oak Capital Management’s Novavax NVAX Stock Holding History

Charter Oak Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-387
Closed -$20K – 626
2022
Q2 		$20K Hold
387
– – ﹤0.01% 473
2022
Q1 		$29K Buy
387
+81
+26% +$7.22K ﹤0.01% 445
2021
Q4 		$44K Buy
306
+268
+705% +$46K 0.01% 371
2021
Q3 		$8K Hold
38
– – ﹤0.01% 609
2021
Q2 		$8K Hold
38
– – ﹤0.01% 607
2021
Q1 		$7K Buy
38
+31
+443% +$6.18K ﹤0.01% 593
2020
Q4 		$1K Buy
+7
New +$744 ﹤0.01% 710

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Charter Oak Capital Management's NVAX Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 387 shares — an estimated $20K sold.

Charter Oak Capital Management first reported a position in NVAX in Q4 2020 and held it in 7 quarters. The position peaked at $44K in Q4 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 387 Novavax shares in Q3 2022, an estimated $20K.
  • Charter Oak Capital Management first reported a position in Novavax in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's Novavax position peaked at $44K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.